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TumorigenesisThe function of Snail2 in mesenchymal tumors is, to date unknown. Using knockdown and overexpre s- 
sion studies, we show that Snail2 regulates migration and invasion of osteosarcoma cells. Knockdown 
resulted in signiﬁcantly decreased motility, rem odelling of the actin cytoskeleton, and loss of cellular pro- 
trusions. Over-expression increased motility, formation of actin-rich cellular protrusions, and altered 
expression of some non-canonical Wnt pathway components whilst decreasing expression of the adhe- 
sion molecule OB-cadherin. Unexpectedly, knockdown also resulted in signiﬁcantly smaller tumors in an 
in vivo CAM assay. Therefore Snail2 may be a potential therapeutic target for clinical intervention of 
osteos arcoma.
 2013 Elsevier Ireland Ltd. Open access under CC BY license.1. Introduction these osteosarc omas. This suggests that the re-expression of high In epithelial tumor types (e.g. breast, lung and ovarian) the 
functions of the Snail zinc ﬁnger transcriptio nal repressors have 
been extensively studied [1]. In this context, the key function of 
Snail2 is similar to its function in embryonic epithelial tissues,
namely the promotion of epithelial-to-mes enchymal transition 
(EMT) [2]. The mechanis m of action is also similar, utilizing tran- 
scriptional repression of epithelial cellular adhesion molecules,
including E-cadher in, thus allowing cells to break their cell to cell 
contacts [3–5], which is an early step in the process of EMT.
During embryonic developmen t Snail2 is present in one tissue 
of mesenchym al origin, namely the developing long bone [6]. How- 
ever its functions in this tissue are largely unknown. Interestingly 
expression is lost with age and in post-natal bone in vivo , Snail2 is 
absent (unpublished observations).
In a recent study, we demonst rated that Snail2 is expressed in 
long bone canine osteosarcomas ; tumors of mesenchym al origin 
[7]. Furthermore our study also showed that there was a strong 
correlation between levels of Snail2 and grade (malignancy) of levels of Snail2 in this tumor type may, in part, be responsible 
for increasing malignancy . Since osteosarcom as are mesenchym al 
tumors the function of Snail2 cannot be to drive changes in epithe- 
lial cell adhesion during EMT, suggesting that it most likely has 
other unknown functions in these, and possibly other, mesenchy- 
mally derived tumor types.
In order to investiga te the function of Snail2 in osteosarcoma,
we generate d stable cell lines in which loss of Snail2 function 
was achieved using small interfering RNA and gain of function 
using CMV promote r driven over-expression. The motility of these 
tumor cells in vitro was assessed using a scratch assay and tumor 
forming ability together with vascular invasion determined in an 
in vivo model. Knockdown of Snail2 resulted in reduced motility 
while over expression of Snail2 resulted in increased motility.
These changes in motility were associated with changes in the 
polymerizat ion of the actin cytoskeleton and in focal adhesion s
as well as altered expression of Wnt5a, sFRP2 and osteoblast cad- 
herin (OB-Cad). Reductio n of Snail2 expression also resulted in re- 
duced tumor forming ability in an in vivo assay. These data indicate 
a role for Snail2 in both motility and tumor formation.
2. Materials and methods 
2.1. Establishment of stable osteosarcoma cell lines 
Stable Snail2 cell lines were derived from canine D-17 and human Saos-2 oste- 
osarcoma cell lines. Knock-down cell lines were produced by stable integration of 
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characterized human Snail2 sequence (50-GGACCACAGTGGCTCAGAA-30) [8], also 
present in dog. Control vector contained a target sequence for eGFP. For Snail2 over- 
expression, the coding sequence of human Snail2, minus the stop codon, was in- 
serted into pcDNA3.1 (Invitrogen) in frame with eGFP, producing a Snail2-eGFP 
fusion protein. Control vector contained the eGFP coding sequence. Cells were 
transfected with construct, plated in 100 mm culture dishes and selected with 
G418 and presence of GFP. Clonal colonies (2–3) of positive cells were ring cloned 
and individually ampliﬁed. A representative clone from each cell line was included.
Overexpression and down-regulation of Snail2 was conﬁrmed by immunoﬂuores-
cent and qRT-PCR analysis. Cells from passages 4–10 were used in subsequent 
experiments.
2.2. Cell culture 
Cell lines were grown in Dulbecco’s modiﬁed Eagle’s medium supplemented 
with 10% (v/v) fetal calf serum, 2 mM L-glutamine, 100 units/ml penicillin and 
100 mg/ml streptomycin. For scratch assays and qRT-PCR, 2.5  105 cells were pla- 
ted onto 12-well plates and 60 mm culture dishes respectively. For immunoﬂuores-
cence 5  104 cells were plated onto 13 mm diameter thermanox coverslips (Nunc,
Rochester, NY). For Wnt5a blocking experiments in vitro , Saos-2 cells overexpress- 
ing Snail2 were plated onto 13 mm diameter coverslips and treated for either 4 or 
24 h with anti-Wnt5a antibody (2 lg/ml; R&D Systems, [9]. Cells were ﬁxed in 4%
paraformaldehyde and their actin cytoskeleton visualized using Rhodamine pahal- 
loidin (Invitrogen Molecular Probes, UK)
2.3. Scratch assays 
Conﬂuent cell monolayers were wounded with a pipette tip to obtain two per- 
pendicular wounds, forming a cross shape. Wounds were photographed at 0, 24 and 
72 h using an inverted microscope (Leica, Solms, Germany). Average distances be- 
tween wound edges were calculated by measuring the uncovered wound area 
and dividing by the width of the ﬁeld of view. Distance migrated was calculated 
by subtracting the average distance between wound edges from that at time 0.
For each experiment a total of 12 wounds were measured per group, and each 
experiment was repeated three times.
2.4. In vivo cell invasion assays 
Fertilized white leghorn chicken eggs (Henry Stewart, UK) were incubated at 
37 C. On day 9 of development [10] the chorio-allantoic membrane (CAM) surface 
was gently lacerated with ﬁlter paper, and a plastic ring (6 mm inner diameter)
placed on this region. 25 ll of medium containing 3  105 control or Snail2 knock- 
down cells was added to the ring and the eggs re-incubated for a further 7 days be- 
fore CAMs were excised and ﬁxed in 4% PFA. Tumor size and cell motility were 
assessed using a Nikon SMZ1500 microscope and DS-2Mv digital ﬂuorescent cam- 
era (Nikon Instruments Inc., Japan). Tumor areas from two separate experiments 
were measured using ImageJ software (NIH, Maryland, US).
2.5. Immunoﬂuorescence
Cells were ﬁxed with 4% PFA for 10 min, and incubated on ice for 10 min in per- 
meabilization buffer (20 mM Hepes, 300 mM Sucrose, 50 mM NaCl, 0.5% TX-100,
3 mM MgCl 2, 0.05% Sodium Azide, pH 7.0). Cells were blocked in 10% Calf Serum 
and incubated with primary antibody overnight at 4 C. Primary antibodies used 
were rabbit anti-Snail2 (4 mg/ml; Santa Cruz, Inc., USA.) and rabbit anti-Paxillin 
(4 lg/ml; Santa Cruz). Coverslips were washed and incubated for 45 min with bio- 
tin conjugated goat anti-rabbit secondary antibody (Dako, Glostrup, Denmark) fol- 
lowed by Strepavidin, Alexa Fluor  555 or 633 (Invitrogen Molecular Probes, UK).
Rhodamine–phalloidin staining was used to visualize actin (Invitrogen Molecular 
Probes, UK). Imaging was performed with a Zeiss LSM 510 laser scanning confocal 
microscope (Carl Zeiss, Inc., Thornwood, NY) or Leica DM4000B light microscope 
(Leica, Solms, Germany).
2.6. Quantitative real-time RT-PCR 
Total RNA was isolated from cells using an RNeasy Plus Mini Kit (Qiagen). cDNA 
was synthesized using Superscript II Reverse transcriptase (Invitrogen Ltd., Paisley,
Scotland, UK) and random hexamer primers. Quantitative real time RT-PCR (qRT-
PCR) was carried out as previously described [11] using QuantiTect SYBR Green 
PCR kit and Opticon 2 LightCycler (MJ Research, Waltham, MA). Primers used were 
against Snail2, OB-Cadherin, Wnt5A, sFRP2 and the housekeeping genes b-actin,
GAPDH and 18S (sequences and conditions in supplemental information ). A relative 
standard curve was constructed for Snail2, OB-cadherin, Wnt5A, sFRP2 and the 
housekeeping genes using serial dilutions of their amplicons, and these standard 
curves were included in each run. Standards were run in duplicate and samples 
in triplicate. The expression levels for all the genes analyzed were normalized to 
b-actin, GAPDH and 18S.2.7. Statistical analysis 
Data are presented as mean ± standard deviation. Statistical comparison of each 
Snail2 modiﬁed cell line and their appropriate control cell line was performed using 
the Student’s t test in Microsoft Excel. In all cases, P < 0.05 was considered 
signiﬁcant.3. Results 
3.1. Generatio n of stable Snail2 over-expressing /knock-down 
osteosarco ma cell lines 
To investigate the functional role of Snail2 in osteosarc oma 
tumorige nesis, stable cell lines were produced which either over- 
expresse d or had reduced levels of Snail2. Overexpression and 
knock-down were conﬁrmed by immunohistoc hemistry and 
qRT-PCR . Antibody labeling showed that levels of nuclear Snail2 
protein were increased in both D-17 and Saos-2 overexpress ing 
cells compare d to controls (Fig. 1a). In contrast, knockdown cells 
showed reduced levels of nuclear Snail2 expression compared to 
controls in both cell lines (Fig. 1a). Analysis of Snail2 expression 
by qRT-PCR in D-17 cell lines matched the results seen for immu- 
nostainin g (Fig. 1b and c). Snail2 transcript levels were increased 
and decreased for overexpres sion and knockdown lines respec- 
tively, and these changes were maintain ed over time in culture 
(Fig. 1b and c). In Saos-2 Snail2 overexpress ing cells, increase in 
levels of Snail2 transcrip ts were only evident at later passage 
numbers (Fig. 1d), even though both low and high passage cells 
produced exogenous GFP tagged Snail2 from the inserted vector.
Equally while immunosta ining showed a decrease in Snail2 
protein levels in shRNA cells (a decrease similar to that seen in 
another study using the same target sequence in an ovarian cell 
line [8]), qRT-PCR analysis showed no decrease (Fig. 1e). This 
may be due to an imperfect match between target and sequence 
which can produce inhibition without mRNA cleavage. Cell lines 
are known to possess SNPs and other genetic changes that 
may affect perfect matching and cleavage [12–14] and thus result 
in the apparent discrepancy between the mRNA and protein 
levels.
3.2. Snail2 modiﬁes osteosarcoma cell morphology 
Control cell lines maintained the same osteoblast-li ke pheno- 
type as parental Saos-2 (human Fig. 2a: A and B and E and F) and 
D-17 (canine Fig. 2b: A and B and E and F) osteosarcom a cell lines.
However , D-17 Snail2 shRNA cells showed a loss of normal osteo- 
blast morphology, losing their characterist ic spindle shape and 
becoming more polygonal or stellate (compare Fig. 2b: E and G),
while Saos-2 Snail2 shRNA cells appeared relatively unchanged 
(compare Fig. 2a: E and G). Cell morphology was largely normal 
in D-17 cells overexpressing Snail2 (compare Fig. 2b: A and C),
however Saos-2 cells overexpress ing Snail2 showed an abnormal 
amoeboid appearance (compare Fig. 2a: A and C).
3.3. Snail2 regulates osteosarcoma cell motility 
Scratch assays were performed to investigate changes in cell 
motility in Snail2 overexpress ing and siRNA osteosarcom a cell 
lines. Knock-down of Snail2 in both canine and human osteosar- 
coma cells resulted in a signiﬁcant reduction in motility from the 
wound edge compared to control cells (Fig. 3a and b). Overexpres- 
sion of Snail2 signiﬁcantly increased motility in Saos-2 but not 
D-17 osteosarcom a cells (Fig. 3a and b). Actin staining of Snail2 
modiﬁed cells at the wound edge revealed morphological modiﬁ-
cations. Control cells at the leading edge showed prominent 
cytoplasm ic protrusions into which actin stress ﬁbers extended 
Fig. 1. Immunoﬂuorescent and qRT-PCR analysis of Snail2 expression levels in transgenic cell lines. (a) immunoﬂuorescent localization of Snail2 protein in human and canine 
control (GFP) and Snail2 overexpressing (Snail2-GFP), control (shRNA-GFP) and Snail2 knockdown (shRNA-Snail2) osteosarcoma cells. Nuclear Snail2 levels were increased in 
Snail2-GFP and decreased in shRNA-Snail2 cells compared with controls GFP and shRNA-GFP expressing cells. Scale bars = 50 lm. (b–e) Total RNA was extracted and Snail2 
mRNA expression levels measured by qRT-PCR. The expression levels were normalized to housekeeping genes, and results are expressed as mRNA copy numbers. In D17 cells 
Snail2 mRNA transcript levels were increased in Snail2-GFP (b) and decreased in shRNA-Snail2 (c) cells compared with controls (GFP and shRNA-GFP). These were stable over 
12 passages. In Saos-2 cells, transcript levels for Snail2 were increased by passage 8 (d) but were not decreased with shRNA for Snail2 at either passage analyzed (e). Results 
are shown as mean ± SD of three replicates.
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(Saos2), M and O (D-17). Saos2 Snail2 overexpressing cells had a
markedly different morphology and actin distribution. Cells at 
the leading edge had increased numbers of smaller protrusions 
containing condensed actin at the tip. In general, the actin 
cytoskeleton appeared disorgani zed in these cells with few, if 
any, stress ﬁbers (Fig. 3c; panel F). In comparison, Saos-2 Snail2 knockdow n cells at the leading edge had less well deﬁned protru- 
sions compared to controls and more prominent and intensely la- 
beled stress ﬁbers (Fig. 3c; panel H).
D-17 Snail2 overexpress ing cells had similar morphology to 
controls, however there appeared to be less prominent stress ﬁbers
(Fig. 3c; panel N). In D-17 Snail2 knockdown cells, the vast major- 
ity did not form any protrusions . In those that did, actin ﬁbers did 
Fig. 2. Snail2 overexpressing/knock-down human osteosarcoma cells show changes in morphology. Phase and ﬂuorescent images of human Saos-2 (a) and canine D-17 (b)
transgenic osteosarcoma cell lines expressing GFP. (a) Human Saos-2 Snail2 overexpressing cells (C and D) appeared smaller and more polygonal when compared to control 
cells (A and B). Saos2 knockdown (shRNA-Snail2) cells (G and H) showed no detectable changes in morphology compared to controls (E and F). (b) Canine D-17 
overexpressing (Snail2-GFP) (C and D) and control (GFP) cells (A and B) showed a spindle shaped morphology, characteristic of osteoblastic cells. Canine Snail2 knockdown 
cells (shRNA-Snail2) (G and H) however acquired an elongated morphology compared to controls (E and F).
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arranged in the direction of migration. (Fig. 3c; panel P).
3.4. Altered gene expression following Snail2 modulation 
qRT-PCR analysis showed that Saos-2 cells overexpressing 
Snail2 had markedly reduced levels of OB-Cad expression 
(Fig. 4a), while decreasing levels of Snail2 increased OB-Cad 
expression. Furthermore Wnt5a showed an increase (Fig. 4c) while 
its antagonist sFRP2 decreased in Snail2 overexpress ing osteosar- 
coma cells compared to controls (Fig. 4b). Expression of these 
two genes was not affected by knockdown of Snail2 (Fig. 4b and c).
Thus stable overexpres sion of Snail2 in Saos-2 cells leads to 
repression of OB-cadherin, which likely results in weaker cell–cell
adhesion combined with an increase in pro-migratory non- 
canonical Wnt signaling due to increased Wnt5a expression which 
is compounded by decrease d expression of its antagoni st sFRP2.
3.5. Snail2 changes osteosarcom a cell focal adhesions and the 
cytoskeleton
In D-17 cells, downregul ation of Snail2 was associate d with a
disorganized cytoskeletal architectur e (Fig. 3c; panel L), however 
the number and size of focal adhesion s appeared normal (Fig. 5B). Conversely in D-17 cells with increased Snail2 the actin 
cytoskeleton appeared normally organized (Fig. 3c; panel J), but 
had fewer stress ﬁbers. In contrast, more focal adhesions were evi- 
dent (Fig. 5D)
In Saos2 cells, down-regul ation of Snail2 had little effect on 
cytoskeletal architectur e (Fig. 3c; panel H) but resulted in greater 
numbers of larger focal adhesions (Fig. 5F). Conversely cells with 
increased levels of Snail2 had fewer actin cables but had a cortical 
distribut ion of actin as well as condensed actin appearing at 
points of cell–cell contact (Fig. 3c; panel F), similar to the distri- 
bution of actin seen in amoeboid cell migration [15]. Further- 
more, paxillin was not detectable by immunosta ining (Fig. 5H)
indicating lack of focal adhesion s, which may explain the ob- 
served weak adherence to substrate in this cell line. This suggests 
that one function of Snail2 in osteosarcoma cells is to regulate 
and/or organize cell adhesion and the actin cytoskeleton. In order 
to determine whether Snail2 regulates the actin cytoskeleton 
directly through Wnt5a, we treated Snail2 overexpress ing cells 
with a Wnt5a blocking antibody [9]. Visualization of the actin 
cytoskeleton showed that neither short (4 h) nor long (24 h)
treatment with this antibody had any observable effect on the 
actin cytoskeleton (Supplemental Fig. 1). This would suggest that 
cytoskeletal rearrangement is not a direct response to upregula -
tion of Wnt5a.
Fig. 3. Snail2 knockdown human and canine osteosarcoma cells show decreased motility. (a) representative images of scratch assays in Saos-2 cells; control, (GFP) and 
(shRNA-GFP), and Snail2 overexpressing (Slug-GFP) and knock-down (shRNA-Snail2) cells at 0, 24 and 72 h. Double headed arrows indicate wound edges. Snail2 down- 
regulating cells showed a decreased motility compared with control. Over-expressing cells were more motile. (b) Graphical representation of average distance moved in 
Snail2 over-expressing/knock-down human and canine cells and controls with time. Results show mean ± SD of 12 wounds. P < 0.05 and P < 0.001. Scale bars = 50 lm. (c)
Rhodamine–Phalloidin stained cultures of wounded human (A–H) and canine (I–P) Snail2 expressing, knockdown and control osteosarcoma cells. Human (Saos-2) Snail2 
overexpressing cells showed a modiﬁed morphology with condensed regions of actin cytoskeleton at the tips of many cells (B and F) compared to their controls (A and E),
however they still migrated as a coherent group. Human Snail2 knockdown cells (D and H) showed similar cell morphology and actin cytoskeleton to that seen in controls (C
and G). In canine (D17) Snail2 overexpressing cells (J and N) the cell morphology and actin cytoskeleton was comparable to that seen in the controls (I and M). Canine Snail2 
knockdown cells (L and P) did not migrate as a coherent group but as small groups of cells which lacked a leading edge and directionality when compared with controls (K and 
O). Scale bars = 10 lm.
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invasiveness
The chick chorio-allantoic membran e (CAM) assay was used to 
study tumor formation and invasiven ess in an in vivo model. Con- 
trol cells formed prominent tumors and were able to invade the stroma, enter and migrate along the vasculature of the CAM 
(Fig. 6a; A, B, C and H, I, J). In contrast, D-17 and Saos-2 Snail2 
knockdow n cells were largely restricted to the region of implanta- 
tion with little invasion of surrounding stroma and vasculature 
(Fig. 6a; D–F and K–M). Control Saos-2 cells developed a primary 
tumor at the site of implantati on in all cases (2.57 mm2 ± 1.37;
Fig. 3. (continued)
Fig. 4. mRNA expression of OB-cad, sFRP2 and Wnt5a in Snail2 overexpressing/down regulating human osteosarcoma cells. Real time PCR revealed that OB-cadherin (a) and 
sFRP2 (b) transcript levels decreased and Wnt5a (c) increased following Snail2 over-expression (Snail2-GFP) compared with controls (GFP). Snail2 knockdown resulted in 
increased OB-cadherin but no alteration in sFRP2 or Wnt5a transcript levels.
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Fig. 5. Effect of Snail2 overexpression/knock-down on focal adhesions. Fluorescent images of paxillin containing focal adhesions (A–H). Snail2 knockdown canine 
osteosarcoma cells showed no marked differences in focal adhesions (B) compared to their controls (A). Snail2 human knockdown cells showed more marked focal adhesions 
(F) than controls (E). Overexpressing canine cells showed an increased number of focal adhesions (D) compared to control (C). Human overexpressing cells showed no 
detectable focal adhesions (H), compared to their controls (G). Scale bars = 50 lm.
176 A.-S. Sharili et al. / Cancer Letters 333 (2013) 170–179n = 12 Fig. 6a; A, B, and G), whereas the majority of Saos-2 Snail2 
knock-down cells did not form a tumor (n = 7/12), and those that 
did formed markedly smaller and less dense tumors 
(1.01 mm2 ± 0.74; P < 0.001) (Fig. 6a; D, E, and G). Similarly, control 
D-17 cells develope d a primary tumor at the site of implantation in 
all cases (3.77 mm2 ± 2.97; n = 9 Fig. 6a; I, J, and N). Almost 40% of 
canine knockdown cells failed to form a tumor and those that did 
(n = 7/11) formed markedly smaller and less dense tumors 
(1.28 mm2 ± 1.27; P < 0.05) (Fig. 6a; L, M, and N).
Histological examination of CAM graft tumors derived from 
control D-17 and Saos-2 cells revealed a population of mesenchy- 
mal osteosarc oma cells separated by chondroid/oste oid matrix,
indicative of chondroblas tic osteosarcoma (Fig. 6b; A and C). Con- 
versely, tumors from D-17 and Saos-2 knock-down cells revealed a
population of early mesenchymal cells contiguous with each other 
separated by minimal matrix (Fig. 6b; B and D).4. Discussion 
In humans and canines approximat ely 80% of osteosarcomas 
originate in the appendicular skeleton [16,17] and these are usu- 
ally more aggressive than those originating at other skeletal sites 
[18]. Long bone osteosarcomas cause local skeletal and soft tissue 
destruction and are highly metastati c [19] with 20% of human pa- 
tients showing clinically detectable metastases on initial presenta- 
tion [20]. Despite advances in clinical managemen t of 
osteosarcom a, the prognosis for osteosarcom a patients remains 
poor, with a reported 5 year survival rate of approximat ely 60%
in metastatic disease [21], even when using chemoth erapy as an 
adjuvant therapy [22].
To date there are no reliable biomarker s that predict clinical 
outcome or could be used in diagnosis to tailor treatments to indi- 
vidual patients. Therefore in order to improve diagnosis and treat- 
ment a better understand ing of the biology of this disease is 
critical. In a recent study we demonstrated a correlation between 
Snail2 expression and tumor grade [7], which suggests that Snail2 
may be involved in osteosarc oma progression, and therefore iden- 
tiﬁes it as a possible target for therapeutic intervention.
Snail2 is an established mediator of malignancy in epithelial tu- 
mors where it induces epithelial –mesenchymal transition (EMT),
promoting both onset and progression of the disease [1]. However 
in osteosarcom a there is no requiremen t for EMT, as these tumors are mesenchym al in origin [23], so the function of Snail2 in these 
tumors remains unknown . We therefore generate d osteosarcoma 
cell lines, with both increased and decreased levels of Snail2 pro- 
tein, to investigate this.
We assessed the ability of these cells to migrate both in vitro 
and in vivo . In the osteosarcom a cell lines tested, decreasing the 
levels of Snail2 signiﬁcantly decrease d cell motility, demonstrat ing 
that Snail2 is required for migration. Conversely, increasing levels 
of Snail2 promoted motility in human Saos-2 cells but not in D- 
17 canine cells, demonst rating intrinsic differences between these 
cell lines. Saos-2 cells are derived from a primary osteosarcoma 
and are not highly metastati c. In contrast, D-17 cells are derived 
from a metastatic osteosarcoma of the lung and therefore may al- 
ready be migrating at their maximum rate, which cannot be en- 
hanced by additional Snail2 activity. Alternatively Snail2 activity 
could be saturated in these cells. In addition to migration, the 
CAM assay assessed the ability of Snail2 knockdown cells to invade 
stroma and intravasate, key steps in cancer cell metastasis. Control 
Saos-2 and D-17 cells were able to invade and intravasate while 
Snail2 knockdown attenuated these abilities. While the exact 
mechanis m underlying these changes is not clear, it may be related 
to the control of MMP expression as Snail2 mediates the upregula -
tion of MMP2 and MMP9 in a range of other cancers [24–26].
To further investigate the molecular mechanisms driving 
changes in motility, we examine d members of two key pathways 
linked to Snail expression in both developmen t and cancer. Snail2 
is well known to inhibit expression of adhesion molecules such as 
E-cadher in, increasing cell migration due to reduced cell–cell adhe- 
sion [27]. E-cadherin is not highly expresse d in osteosarcoma cells 
[28], however Snail2 may also regulate expression of other cadher- 
ins, such as mesenchymal cadherin (OB-cadherin/CDH11) [29],
known to be expressed in osteosarcom as [29]. We have shown that 
expression of OB-cad is indeed inhibited by Snail2, which would 
promote cell migration and that knockdown of Snail2 allows for 
upregula tion of OB-cad. In keeping with this, it has previously been 
shown that overexpres sion of OB-cadherin in osteosarcomas inhib- 
its migration and reduces metastasis [30]. Furthermore a higher le- 
vel of expression of OB-cadherin/C DH11 has been correlated with 
increased patient survival in osteosarcoma [31].
The second molecule investiga ted, Wnt5a, has been described 
as a tumor suppressor [32]. However, more recent evidence sug- 
gests it is a potent inducer of cell motility in a number of tumor 
types and cell lines, including osteosarc oma [33]. A recent paper 
Fig. 6. Knock-down of Snail2 decreases osteosarcoma growth and cell invasiveness in vivo . (a) Representative images of tumors from control (shRNA-GFP) and knock-down 
(shRNA-Snail2) canine and human cell lines grown on the CAM. A, D, H, and K: bright ﬁeld images showing representative examples of rings containing tumors derived from 
Snail2 control and knock-down osteosarcoma cells (outlined) (10 magniﬁcation). B, E, I, and L: higher magniﬁcation ﬂuorescent images of A, D, H and K (30 magniﬁcation)
respectively. C, F, J, and M: ﬂuorescent images showing GFP expressing cells invading blood vessels in control but not Snail2 knock-down tumors (arrows). Visualization of 
CAM vessels (arrows) showing GFP-expressing control cells inside the vasculature outside the ring (J). Note that Knock-down cells have not intravasted the CAM vessels 
(arrows) (F and M). G and N: graphs illustrating the mean tumor area. P < 0.05. Scale bars = 1 mm. (b) A: Saos-2 control tumor. Chondroblastic osteosarcoma with pale bluish 
chondroid (cart; arrow) and eosinophilic pink osteoid (ost; arrow) matrix. B: Saos-2 Snail2 knockdown tumor. Large polygonal cells with minimal matrix produced 
(arrowheads). C: D-17 control tumor. Spindle shaped osteoblast like cells (arrow head) separated by bony matrix. D: D-17 Snail2 knockdown tumor. Population of early 
mesenchymal cells contiguous with each other and not separated by matrix. ob: osteoblast cells; Ost: osteoid; cart: cartilage; pm: polygonal mesenchymal cells; m:
mesenchymal cells; c: CAM.
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(Snail1) and Wnt5a expression in Saos-2 cells [34]. Overexpressi on 
of Snail2 increases Wnt5a expression in Saos-2 cells and it is likely 
that this has a role in the increased motility observed. Previous 
analysis of the role of Wnt5a in gastric cancer cell lines indicated 
that loss of Wnt5a resulted in changes in the actin cytoskeleton 
[35]. In order to conﬁrm whether Snail2 modulate s cytoskeletal 
structure directly through Wnt5a, Saos-2 overexpressing cells 
were treated with a Wnt5a blocking antibody [9]. This resulted 
in no observable changes in cytoskeletal arrangement, suggesting 
that the effect of Snail2 on cytoskeletal reorganizati on is not a di- 
rect response to Wnt5a. It is therefore possible that Wnt5a is not 
the driving force for cytoskeletal changes and that the effect of 
Snail2 on the cytoskeleton is mediated by other mechanis ms such 
as Rho-GTPas es. In this context, Snail1 induced motility has been 
very recently reported to be mediated by Rho GTPases [36]. This 
raises the potential that Snail2 may also promote motility via 
Rho GTPases in osteosarcom a cells.
The lack of effect seen with Wnt5a neutralizing antibody does 
not rule out a role for Snail2 in maintaining and/organizi ng the 
cytoskeleton in link with cell motility. Therefore we examined in 
detail the cytoskeleton and focal adhesion s.
In Saos-2 cells with decreased levels of Snail2, there were more 
prominent actin cables however they had fewer cellular protru- 
sions, indicating a less migratory phenotype despite having more 
focal adhesions. In contrast, cells overexpressing Snail2, had re- 
gions of condensed actin in numerous small protrusions , reminis- 
cent of structures described as invadopodia in metastati c cells 
[37] and indeed these cells were highly motile. Strikingly, they 
lacked paxillin containing focal adhesions.
Similar to Saos-2 cells, D-17 cell lines had fewer cellular protru- 
sions when Snail2 levels were decreased, but no change in focal 
adhesions. Unlike the human cells, there was little effect on either 
the actin cytoskeleton or focal adhesion s when Snail2 levels were 
increased and these cells did not have increased motility. This sug- 
gests that Snail2 has a prominent role in directing actin polymeri- 
zation to form cell protrusions. The formation of cellular 
protrusions is largely controlled by actin related protein complexes 
(Arp 2/3) and actin severing proteins at the leading edge [38].
While Snail2 has been linked to disorganization of the actin cyto- 
skeleton in pancreati c cancer cells [26], its role in cellular protru- 
sions (i.e. lamellopidia, ﬁlopodia) has not been explored and this 
warrants further investiga tion.
Changes in focal adhesions will also alter cell migration dynam- 
ics. However the changes in focal adhesion in the human cells 
would initially appear to be contradic tory to their migratory phe- 
notype. It has previously been shown that knockdown of paxillin 
in highly metastatic osteosarcom a sub-lines M112 and 132 inhibits 
migration [39], which is in direct contrast to our observati on that 
loss of paxillin in Saos-2 cells correlates with increased motility.
However ﬁbroblasts derived from paxillin knockout mice retained 
the ability to migrate [38], suggestin g that paxillin expression is 
not a direct correlate with migration. However, loss of paxillin/fo- 
cal adhesions may explain changes in morphology of Snail2 over- 
expressing cells, as paxillin deﬁcient cells have previously been 
reported to have similar disorganized cortical cytoskeleton and de- 
layed spreading in culture [40].
Another ﬁnding pertinent to the non-canonic al Wnt signaling 
pathway is that overexpress ion of Snail2 reduces the expression 
of sFRP2, an inhibitor of Wnt5a signaling [41]. sFRP2 has not pre- 
viously been identiﬁed as a target for Snail2 transcriptio nal repres- 
sion in either physiological or pathological settings. The net result 
of downregul ating this gene would be potentiation of the Wnt5a 
signal. Indeed, in cervical cancer it has been shown that expression 
of sFRP2 attenuates Wnt signaling and suppresses cancer cell 
growth [42]. Knockdown of Snail2 did not affect either sFRP2 or Wnt5a expression. This may suggest that these genes are not direct 
targets of Snail2.
A decrease in Snail2 expression also resulted in the generation 
of smaller tumors in the CAM assay. Reducing Snail2 expression re- 
duced osteosarcom a cell migration and increased OB-cad expres- 
sion, thus increasing cell–cell adhesion, which should promote 
tumor formation. However, cell–cell adhesion is not the only factor 
that drives tumorige nesis and the tumor microenvironmen t and 
matrix scaffold composition (such as collagen and ﬁbronectin) is 
paramou nt for tumor formation [21,43]. Thus Snail2 may also reg- 
ulate the expression of these proteins in osteosarcom as. Further 
studies are required to determine if this theory is correct.
Collectiv ely, this study shows for the ﬁrst time the requiremen t
for Snail2 for motility and tissue invasion in human and canine 
osteosarc oma cells. Furthermore we also show that decreasing 
the levels of Snail2 impaired tumor developmen t in vivo . Thus,
the clinical beneﬁts of selective ly blocking Snail2 in patients with 
osteosarc oma may be twofold, as it may decrease metastasis,
which is a leading cause of death, and also inhibit tumor growth.Acknowled gements 
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